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A B S T R A C T
The growing interest in ultra-high ﬁeld MRI, with more than 35.000 MR examinations already performed at 7 T,
is related to improved clinical results with regard to morphological as well as functional and metabolic
capabilities. Since the signal-to-noise ratio increases with the ﬁeld strength of the MR scanner, the most evident
application at 7 T is to gain higher spatial resolution in the brain compared to 3 T. Of speciﬁc clinical interest for
neuro applications is the cerebral cortex at 7 T, for the detection of changes in cortical structure, like the
visualization of cortical microinfarcts and cortical plaques in Multiple Sclerosis. In imaging of the hippocampus,
even subﬁelds of the internal hippocampal anatomy and pathology may be visualized with excellent spatial
resolution. Using Susceptibility Weighted Imaging, the plaque-vessel relationship and iron accumulations in
Multiple Sclerosis can be visualized, which may provide a prognostic factor of disease. Vascular imaging is a
highly promising ﬁeld for 7 T which is dealt with in a separate dedicated article in this special issue. The static
and dynamic blood oxygenation level-dependent contrast also increases with the ﬁeld strength, which
signiﬁcantly improves the accuracy of pre-surgical evaluation of vital brain areas before tumor removal.
Improvement in acquisition and hardware technology have also resulted in an increasing number of MR
spectroscopic imaging studies in patients at 7 T. More recent parallel imaging and short-TR acquisition
approaches have overcome the limitations of scan time and spatial resolution, thereby allowing imaging matrix
sizes of up to 128×128. The beneﬁts of these acquisition approaches for investigation of brain tumors and
Multiple Sclerosis have been shown recently. Together, these possibilities demonstrate the feasibility and
advantages of conducting routine diagnostic imaging and clinical research at 7 T.
Introduction
Three major MR vendors currently provide 7 T MR scanners for
ethically approved clinical research. The number of installations in
operation has increased to over 60 during the last several years. Ultra-
high ﬁeld MRI has been shown to supply added morphologic (Springer
et al., 2016; Trattnig et al., 2015), functional (Beisteiner et al., 2011;
Goncalves et al., 2015), metabolic (Bogner et al., 2011), and other
biochemical (Biller et al., 2016; Zaiss et al., 2015) information about
the brain.
The signal-to-noise ratio (SNR) increases with the static magnetic
ﬁeld strength (B0), which can be translated into higher spatial resolu-
tion and contrast. A recent report has shown that the image SNR may
even scale supralinearly with the B0 (SNR~B0
1.65) under certain
conditions (Pohmann et al., 2016). Additional improvement in SNR
(two-fold to six-fold depending on the brain region) is achieved at 7 T
by eﬃcient coil design (de Zwart et al., 2002; Wiggins et al., 2005;
Wiggins et al., 2006). A volume coil is usually used for transmission to
produce a relatively uniform excitation ﬁeld, and phased array coils for
high sensitivity detection, where each coil element is designed to
optimize the SNR in a region adjacent to the coil. Application of
phased arrays enables also parallel imaging (Griswold et al., 2002;
Pruessmann et al., 1999), for which the SNR penalty at ultra-high ﬁelds
is reduced due to onset of far-ﬁeld behavior of the involved radio-
frequency (RF) ﬁelds (Wiesinger et al., 2004). This allows accelerations
above three-fold with a relatively small cost in SNR, which reduces the
sensitivity of a given sequence to motion and can increase measure-
ment feasibility in a clinical setting.
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The most evident advantage at 7 T in neuroimaging is to gain
higher spatial resolution and contrast for imaging gray and white
matter disease. In the last few years, in vitro studies have shown new
insights into the pathology of the cerebral cortex at 7 T, such as, for
example, in cortical lesions in cerebrovascular disease (De Reuck et al.,
2014) and Multiple Sclerosis (MS) (Yao et al., 2014), or in malforma-
tions of cortical development (MCDs), e.g., in Focal Cortical Dysplasias
(FCDs) (Zucca et al., 2016) and a growing number of clinically focused
in vivo studies have been performed at 7 T (De Ciantis et al., 2016; de
Graaf et al., 2012; Harrison et al., 2015; van Veluw et al., 2013).
Imaging of the hippocampus, especially its subunits, and the occasion-
ally only subtle changes engendered by recurrent epileptic seizures, is
assumed to proﬁt from higher spatial resolution (Wisse et al., 2012).
MR neuroimaging also beneﬁts from an increase in tissue contrast.
Phase images from T2
*-weighted sequences acquired at 7 T are
characterized by an outstanding tissue contrast (Duyn et al., 2007),
since structures with slightly diﬀerent magnetic properties introduce
detectable ﬁeld variations at high B0. These ﬁeld gradients are mostly
prominent in the proximity of tissues with a high iron content (Haacke
et al., 2005), densely distributed myelinated axons (Lodygensky et al.,
2012) and veins, where the deoxyhemoglobin level is high
(Reichenbach et al., 1997). In Susceptibility Weighted Imaging (SWI)
valuable phase information is incorporated into magnitude imaging
(Reichenbach and Haacke, 2001), using a phase mask which enhances
the contrast between structures of interest. At 7 T, in the absence of a
homogeneous volume reference coil (e.g. a body coil), consideration
needs to be given to how phase images from the array coils are
combined as the phase measured with each coil element reﬂects not
only magnetic properties of the tissue, but also of the coil sensitivity
proﬁle, which needs to be removed. Using coil combination methods
not optimized for ultra-high ﬁeld applications (such as homodyne
ﬁltering (Noll et al., 1991)) may lead to the appearance of microbleeds,
with potential clinical consequences (Haacke et al., 2015). Several
methods for optimal coil combination in the absence of a homogenous
reference coil have been proposed in recent years (Parker et al., 2014;
Robinson et al., 2011; Robinson et al., 2015), the relative merits of
which have been reviewed elsewhere (Robinson et al., 2016). 7 T may
allow a superior assessment of the plaque-vessel relationship (Dal-
Bianco et al., 2015b), iron deposits (Bagnato et al., 2011b), and
temporal evolution (Absinta et al., 2013) in MS employing SWI than
at lower B0. Also the depiction of hemorrhagic diﬀuse axonal injury
(Moenninghoﬀ et al., 2015), and the evaluation of the microvasculature
in gliomas may be improved using SWI at 7 T (Di Ieva et al., 2013).
Because MR spectroscopy (MRS) has had to overcome several
major technical challenges at 7 T (Moser et al., 2012; Posse et al.,
2013), most prior studies are methodological in nature. Only recently
have several papers with clinical application been published that
highlight speciﬁc advantages of 7 T MRS and MR spectroscopic
imaging (MRSI) for selected brain disorders, e.g., brain tumors
(Heckova et al., 2016; Li et al., 2015) and MS (Srinivasan et al.,
2010; Strasser et al., 2016a), by providing access to a far larger number
of chemical compounds (Bogner et al., 2012; Tkáč et al., 2001).
The number of in vivo studies that compare 7 T with 3 T in
neuroimaging is growing (Bian et al., 2014; de Graaf et al., 2013;
Madai et al., 2012; Springer et al., 2016; Tallantyre et al., 2009),
demonstrating concerted interest in evaluating the potential of ultra-
high ﬁeld (UHF) for clinical use.
The aim of this review is to provide an overview of the additional
clinical beneﬁt of 7 T MRI compared to lower B0 for clinical MR
examinations in neuroimaging.
Multiple sclerosis
Cortical lesions
The number of detected cortical lesions has been shown to be
higher at 7 T, with about 30–50% of histopathologically conﬁrmed
cortical MS lesions being detected at 7 T (Van Munster et al., 2015)
(Fig. 1).
In patients with MS, cortical lesions can be more precisely classiﬁed
as cortically, cortically-subcortically or solely subcortically occurring
due to the higher spatial resolution at 7 T in comparison to 3 T, mainly
on MP2RAGE images but also using 3D DIR (Springer et al., 2016).
This is consistent with a study by Tallantyre et al. (2010) in which high-
resolution 7 T imaging using T1w MP-RAGE (Mugler and Brookeman,
1990) was shown to be helpful in deﬁnitively assessing the localization
of lesions with respect to the cortical/subcortical boundary compared
to 3 T imaging employing FLAIR, DIR, and T1w MP-RAGE. Harrison
et al. found that, in MS, Expanded Disability Status Scale (EDSS)
scores accorded more with cortical lesion volume than WM lesion
volume (Harrison et al., 2015), supporting the clinical relevance of
cortical lesions. The inversion recovery sequence FLAIR, in which the
inversion time is chosen such that CSF contributes negligibly to the
total signal is a highly useful sequence in cortical lesion detection at 7 T
Fig. 1. Sagittal 3D DIR of an MS patient acquired at 3 T (A) and 7 T (B). A cortical lesion - type I neocortical lesion (NL) (Yao et al., 2014) (leukocortical lesion, mixed lesion) (red
arrow) - is more clearly depicted at 7 T.
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(Hajnal et al., 1992). There are, however, problems with high Speciﬁc
Absorption Rate (SAR) due to the utilization of multiple 180° refocus-
ing pulses, which usually allows only a thin brain slab to be imaged
using 2D, or requires the use of thick slices. Whole brain imaging
becomes feasible in 3D with application of variable ﬂip angle readouts,
i.e. SPACE (Grinstead et al., 2010). In a study by Kilsdonk et al. (2013)
the highest number of cortical gray matter (GM) lesions were detected
using 3D-FLAIR; 89% more than by using 3D-DIR, 87% more than
when employing 2D-T2w and 224% more than using 3D-T1w. The
higher number of detected GM lesions on 3D-FLAIR than on 3D-DIR
was mostly due to a better detection of mixed lesions. In the patient-
wise comparison the higher total GM and mixed-lesion detection at 3D-
FLAIR was statistically signiﬁcant; the detection of purely intracortical
lesions was higher with 3D-DIR compared with the other sequences,
although this diﬀerence was not statistically signiﬁcant. Daams et al.
(2013) concluded that future studies should focus on comparing
diﬀerent sequences at ultra-high ﬁeld, such as DIR, T2, and FLAIR.
In our experience this should be performed in combination with
MP2RAGE (Marques et al., 2010), because no deﬁnite consensus exists
as to the optimal sequence for cortical lesion depiction. MP2RAGE
provides image quality which is superior to its predecessor MP-RAGE,
because T2* and receive ﬁeld (B1
-) dependencies are removed by the
combination of two images with diﬀerent inversion times. The B1
-
ﬁeld
becomes visibly heterogeneous at 7 T, which is observable in MP-RAGE
images and can hinder correct diagnosis in brain regions aﬀected by
strong signal decay.
FLAIR images at 7 T have a hyperintense rim at the pial surface of
the cerebral cortex which corresponds to the outer, glia-rich layers of
the cortex (layers I – III) (van Veluw et al., 2015). Absinta et al.
described the higher background T2 relaxation times of the cortex
relative to white matter (WM), that are highest in the subpial cortical
layers, as a reason for low cortical lesion contrast (Absinta et al.,
2016a). Beneath the hyperintense signal of outer, glia-rich layers of the
cortex we observe a slight decrease in the signal of the cortex and
lesions – both in the cortex and WM - compared to 3 T on both 3D DIR
and 3D FLAIR. Subpial lesions - the most prevalent subtype of cortical
demyelination - broadly comprise the subpial layers of the cortex, and
the depths of the sulci (Absinta et al., 2016a). Plaque-like subpial
Fig. 2. Axial SWI images of an MS patient acquired at 3 T (A) and 7 T (B) and corresponding T2-weighted images acquired at 3 T (C) and 7 T (D). Note iron deposits (rims) and central
vessels within MS lesions in SWI images (A, B) (white arrows). In T2-weighted images central vessels are diﬃcult to detect (C, D) (white arrows).
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demyelination is a speciﬁc characteristic of MS; it is found seldom in
other inﬂammatory and neurodegenerative CNS conditions (Fischer
et al., 2013).
MRI signal changes deduced from the interruption of the cortical
architecture may be used to improve subpial lesion detection (Absinta
et al., 2016a; Mainero et al., 2015). Mainero et al. (2015) evaluated
diﬀerences in laminar quantitative T2* maps throughout the cortical
width, which at 7 T are sensitive to tissue composition at a cellular level
(Zwanenburg et al., 2011). They found that patients suﬀering from MS
showed signiﬁcantly increased T2*, which was not dependent on
cortical thickness, consistent with cortical myelin and iron loss, in
comparison to controls. In early disease, T2* changes were focal and
primarily limited to a 25% superﬁcial depth, and also localized adjacent
to cortical sulci. In later stages of the disease, T2* changes aﬀected
deeper cortical laminae, multiple cortical areas, and gyri. Their ﬁndings
reveal a gradient in the existence of cortical pathology throughout the
stages of MS. Hence they demonstrated in vivo evidence for the
existence of a cortical pathological process driven from the pial surface.
In a study by Nielsen et al. (2012), more cortical, especially subpial,
lesions were detected in the bilateral precentral gyri, using T2* FLASH
at 7 T compared to the DIR sequence and the multi-echo MPRAGE
(MEMPR) at 3 T. With 7 T T2* FLASH data considered the reference
standard, the sensitivity of the DIR sequence at 3 T in vivo for cortical
lesions was modest according to the MR in MS (MAGNIMS) consensus
guidelines (Geurts et al., 2011). It was suggested by the authors that
7 T be established as the gold standard in future consensus guidelines.
Nielsen et al. (2013) also found, using T2*-weighted images at 7 T,
that, in a heterogeneous MS cohort, type III-IV cortical lesions had the
strongest relationship to physical disability. There was a signiﬁcant
correlation with four of 11 neuropsychological test variables. Also for
WM lesion volume, as well as for type I cortical lesions, a signiﬁcant
association with six of 11 neuropsychological test variables was shown.
The authors concluded that leukocortical and subpial cortical lesions
detected on 7 T FLASH-T2* sequences may serve as potential biomar-
kers of neurologic and cognitive status in patients suﬀering from MS.
Central venules
A number of authors have described central venules in MS lesions
as a central feature of the disease. The phenomenon was ﬁrst reported
by Rindﬂeisch (1863) and by Charcot (1868). More recently, the
perivenular distribution of MS lesions has been highlighted by high-
ﬁeld and ultra-high ﬁeld MRI, and disease speciﬁcity has been
attributed to this distribution (Kilsdonk et al., 2014b; Mistry et al.,
2013; Rae-Grant et al., 2014; Tallantyre et al., 2011) (Fig. 2).
Tallantyre et al. (2009) compared 3 T and 7 T T2* imaging in 358
brain lesions identiﬁed on 3 T FLAIR images in seven patients with
demyelinating brain disease with a focus on the presence or absence of
a central vessel within the lesion. A central vessel could be identiﬁed in
45% of visible lesions using 3 T T2* weighted imaging, and in 87% of
visible lesions at 7 T. Tallantyre et al. (2011) also addressed the
question of whether it is feasible to employ T2* imaging at 7 T to
distinguish between MS and asymptomatic non-MS WM brain lesions.
Twenty-eight patients with known MS and a control group of 17 non-
MS patients with cerebral WM lesions were examined. The location of
the WM lesions was identiﬁed as an important factor for the diﬀer-
entiation, as in patients with MS 80% of the lesions had a perivenous
appearance in comparison to just 19% in patients without MS. Using
7 T T2*-weighted MRI, a reliable discrimination between all patients
with clinically deﬁnite MS ( > 40% lesions perivenously localized) from
those without clinical MS ( < 40% lesions perivenously localized) was
possible. The presence of a perivenous lesion was shown to be more
predictive of MS than a subcortical or a periventricular lesion location.
Using T2* imaging at 7 T, Mistry et al. (2013) studied twenty-nine
patients with brain lesions detected on clinical MRI, who were referred
because of possible MS. They reported a 100% positive and negative
predictive value for the diagnosis of MS, according to whether more or
less than 40% of their lesions were perivenous. These results need to be
validated in larger and multicenter patient cohorts in the near future.
Iron deposits
Iron deposits in brain parenchyma may be linked to a multiplicity of
pathological processes in patients with MS and might potentially be
used as an in vivo MRI marker of disease pathology. Brain tissue iron
content was assessed by Bagnato et al. (2011a) in two patients with MS.
The authors employed a 3D multi-echo gradient echo sequence to
reconstruct R2* maps and correlate the tissue iron content with
histological analyses. An increase in R2* was described as being highly
sensitive for the detection of iron depositions although signal altera-
tions were not always associated with iron in the histological analyses,
which was tentatively attributed to iron loss in sample preparation. The
authors concluded that the identiﬁcation of iron should be evaluated in
combination with additional topographical and clinical information.
The sources of iron identiﬁed included oligodendrocytes in normal-
appearing white matter (NAWM) and activated microglia / macro-
phages at the borders of WM lesions, as well as iron precipitation in
aggregates typical of microbleeds in WM lesions. This is in accord with
Hametner et al. (2013), who reported that iron was apparently released
from dying oligodendrocytes in active MS lesions, leading to an
extracellular accumulation of iron and an uptake into macrophages
and microglia. The latter showed signs of cell degeneration.
Furthermore, the authors noted that iron accumulated in astrocytes
and axons at lesion edges and within the centers of lesions.
Both Absintha et al. and Hammond et al. proposed that the
peripheral paramagnetic rim (Absinta et al., 2013, 2016b; Dal-Bianco
et al., 2015a; Hagemeier et al., 2012; Hammond et al., 2008; Yao et al.,
2012) that can be perceived on T2*- magnitude and susceptibility-
weighted phase images (Fig. 2) is a potential marker of chronic active
lesions (Absinta et al., 2016b; Hammond et al., 2008). The studies
performed to date are in complete concordance about the extent to
which the MR magnetic susceptibility signal change in the lesion rim
may be caused by iron deposits (iron-laden macrophages, ferritin, or
hemosiderin deposits) (Bagnato et al., 2011a; Pitt et al., 2010; Walsh
et al., 2013; Yao et al., 2012) or by oxidative stress and rupture of the
microarchitecture of the parenchyma, including demyelination.
Absinta et al. (2013) showed that when combining dynamic
contrast-enhanced MRI with T2* imaging, particularly phase data at
7 T, the front of demyelination and inﬂammation in MS lesions may be
identiﬁed. They demonstrated that in centripetally enhancing lesions,
the paramagnetic phase rim reﬂects the initial opening of the blood
brain barrier at the inﬂammatory lesion edge. In a more recent study at
7 T, Absinta et al. (2016b) examined centripetally and centrifugally
enhancing lesions in 17 patients with MS. While in centripetal lesions,
a phase rim appeared simultaneously with initial contrast enhance-
ment, no centrifugal lesions showed phase rims at any point in time.
The phase rim in 12 of 22 centripetal lesions persisted after enhance-
ment resolved. The centripetal lesions with a persistent rim had less
volume shrinkage and became more T1 hypointense between 3 and 12
months in comparison to the centripetal lesions with a transient rim.
Persistent rims pathologically corresponded to iron-laden inﬂamma-
tory myeloid cells at the edge of chronic demyelinated lesions.
With respect to MS speciﬁcity, paramagnetic rims have not been
observed in vascular lesions (Kilsdonk et al., 2014b), and are seldom
present in Susac syndrome (Wuerfel et al., 2012). They may be
observed in infectious and neoplastic disorders (Absinta et al.,
2016a). Sinnecker et al. (2015) investigated a rare case of the
simultaneous presentation of natalizumab-associated Progressive
Multifocal Leukoencephalopathy (PML) and ongoing MS activity and
found that ultra-high-ﬁeld MRI is able to diﬀerentiate between early
PML and MS lesions. Whereas a central vein was visible within ring-
enhancing MS plaques on 7 T T2* imaging, punctate or milky way-like
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T2 lesions were apparent before the development of conﬂuent PML
lesions. In another study Sinnecker et al. (2012) observed that it was
possible to distinguish Neuromyelitis Optica Spectrum Disorders
(NMOSDs) from MS at 7 T, where the protocol incorporated T2*-
weighted FLASH and FLAIR sequences. They compared 10 patients
with NMOSDs with 18 patients suﬀering from MS. While a central vein
was prevalently visible within MS plaques (92%) and a characteristic
hypointense rim (23%), the appearance of WM changes in NMOSDs
was nonspeciﬁc; they were sporadically neighbored by a blood vessel
(35%) and a hypointense rim was identiﬁed seldomly (2%). Cortical
pathology was not present in patients with NMOSDs.
Several groups have used a fusion of a FLAIR sequence and a blood-
sensitive sequence, e.g., SWI (Grabner et al., 2011) or T2* imaging, to
examine the relation of intraplaque veins and plaque development in
MS over time (Dal-Bianco et al., 2015b), and to facilitate the
diﬀerentiation of MS and microangiopathic lesions at 7 T (Kilsdonk
et al., 2014b). Kilsdonk et al. correlated three morphological properties
of MS lesions (the presence of a central vessel within lesions; the
presence of hypointense rims around MS lesions; the presence of
hypointense lesions on T2*) with the patient's clinical characteristics,
but found that these properties did not show a relationship to clinical
characteristics or MS disease subtypes (Kilsdonk et al., 2014a). Dal-
Bianco et al. described a relationship between veins and plaque
development in MS at 7 T, deducing that increased apparent venous
calibers in early MS plaques may be due to increased venous diameters
or increased oxygen consumption (Dal-Bianco et al., 2015b).
Cerebrovascular disease
Cortical microinfarcts (CMIs) are small infarcts (between 50 μm
and a few mm) that usually remain undetected with conventional MRI
ﬁeldstrengths or at autopsy (Smith et al., 2012; van Veluw et al., 2013).
Van Veluw et al. (2013) demonstrated the potential of ultra-high-ﬁeld
MRI to detect in vivo cortical microinfarcts. Cortical cerebral micro-
infarctions were studied by Van Veluw et al. employing 3D FLAIR, 3D
T2w Turbo Spin Echo (TSE) and 3D T1w at 7 T in 22 elderly subjects,
and in 15 formalin-ﬁxed coronal brain slices of six subjects with
Alzheimer's disease and vascular pathology. In the latter group six
lesions, with MRI morphology similar to the 15 cortical lesions of the
ﬁrst group, were correlated to histopathology, and of these six cortical
lesions ﬁve were veriﬁed as cortical microinfarcts.
A study by De Reuck et al. (2014) demonstrated that the detection
of diﬀerent types of CMIs is enabled by 7 T MRI. They used post-
mortem 7 T MRI in comparison with the pathological examination to
study CMI in 157 brains of patients with dementia – amongst them 18
with vascular disease and 12 with Alzheimers disease (AD) associated
with cerebral amyloid angiopathy (AD-CAA). Signiﬁcantly more CMIs
were detected in patients with vascular disease and AD-CAA. The mean
number of CMIs detected by 7 T MRI and by neuropathological
examination were comparable.
In another study, more CMIs were detected in AD patients than in
control subjects. The number of CMIs corresponded to global cognitive
performance and their presence was primarily attributed to AD rather
than to Cerebral Amyloid Angiopathy (CAA) (van Rooden et al., 2014).
In cerebrovascular disease, cortical lesions can be more precisely
classiﬁed as cortically, cortically-subcortically or solely subcortically
occurring due to the higher special resolution at 7 T in comparison to
3 T, mainly on MP2RAGE images, but also using 3D DIR (Springer
et al., 2016).
An overview of 7 T imaging of Small Vessel Disease (SVD) was
presented in the work of Benjamin et al. (2015). Madai et al., (2012) in
their study on ischemic stroke, which encompassed lacunar strokes,
demonstrated that the internal structure of stroke lesions was deli-
neated with higher detail on the 3D MPRAGE at 7 T in comparison to
3 T. Improved image contrast at 7 T between lesions and healthy tissue
enabled better depiction of periinfarct alterations.
Potter et al. (2015) suggested that enlarged perivascular spaces are
an additional MRI marker for SVD. In their study they were associated
with age, lacunar stroke, and white matter lesions. Using 7 T MRI, the
depiction of perivascular spaces was improved and they could be
visualized in greater detail than at 3 T (Madai et al., 2012). Another
study reported that the level of enlargement of juxtacortical perivas-
cular spaces was signiﬁcantly related to CAA severity; hence, enlarged
juxtacortical perivascular spaces may be a potential marker for the
severity of CAA (van Veluw et al., 2016).
Microbleeds
Conijn et al. (2011) described ﬁndings showing that in comparison
to a 3D T2*-weighted sequence at 1.5 T, the presence and number of
detected cerebral microbleeds (CMB) were increased using a 3D dual-
echo T2*-weighted sequence at 7 T. Furthermore, that the reliability of
the depiction of CMBs improved. Bian et al. (2014) demonstrated that
SWI at 7 T was more sensitive for depicting CMBs in subjects treated
with radiotherapy than SWI at 3 T, when the localization of the CMBs
was not in regions with prominent susceptibility artifacts, which occur
due to stronger signal dephasing in regions with substantial B0
inhomogeneities at 7 T. Theysohn et al. (2011), employing high-
resolution SWI with an excellent phase contrast at 7 T, could depict
129 CMBs, in comparison to 75 at 1.5 T when employing clinical SWI;
when applying a T2* imaging sequence they could depict 101 CMBs at
7 T and 33 at 1.5 T.
Moenninghoﬀ et al. (2015) showed that for the detection of
hemorrhagic diﬀuse axonal injury 7 T SWI was more sensitive in
comparison to 3 T SWI, a statistically signiﬁcant ﬁnding.
Mesial Temporal Lobe Epilepsy (MTLE)
Mesial Temporal Sclerosis (MTS)
In Mesial Temporal Lobe Epilepsy (MTLE), a higher diagnostic
conﬁdence for the diagnosis and exclusion of Mesial Temporal
Sclerosis (MTS) including which subﬁelds were aﬀected was demon-
strated at 7 T compared to 3 T. (Springer et al., 2016) (Fig. 3). This was
primarily attributable to the higher spatial resolution at 7 T, speciﬁcally
in the coronal T2 weighted TSE sequence. Even though the hippocam-
pus is quite close to the skull base, TSE sequences are quite robust to
susceptibility artifacts in that area. Additionally, TSE at 7 T is an
excellent choice in discrimination between diﬀerent tissue types
because of the increased T1 and decreased T2 relaxation times.
In-plane spatial resolutions of up to 100 μm (Prudent et al., 2010)
and a slice thickness of between 0.7 and 3 mm, may be obtained in vivo
using T2-weighted imaging (Theysohn et al., 2009; Wisse et al., 2012).
Wisse et al. (2012) demonstrated that it is feasible to delineate the
main subunits of the hippocampus along its length at 7 T in vivo.
Patients suﬀering from Temporal Lobe Epilepsy (TLE) in clinical
practice are preoperatively evaluated, including imaging of the mesial
temporal lobe at 1.5 or 3 T, where the superiority of 3 T compared to
1.5 T for volumetry and morphological details has already been shown
in recent studies (Chakeres et al., 2005; Theysohn et al., 2009).
Sequence protocols at 7 T typically enable a morphological delinea-
tion of the internal hippocampal structures in detail due to the higher
spatial resolution (Breyer et al., 2010). Coras et al. (2014) employed T2
weighted sequences and Diﬀusion Tensor Imaging (DTI) at 7 T to
investigate 15 nonsclerotic and 18 sclerotic hippocampi ex vivo, and
images were correlated to histology. Diﬀerences in signal intensity were
attributed to seven unequivocally discernable layers and to anatomic
borders in the case of nonsclerotic hippocampi. A signiﬁcant loss of
volume and an increase in signal intensity along the pyramidal cell
layer was revealed in all sclerotic hippocampi. An assignment of the
increase in signal intensity on T2 weighted images to a deﬁnite
histopathologic correlate such as decreased neuronal or increased glial
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cell density was not possible, although intrahippocampal ﬁber tracts
and projections were distorted in samples of hippocampal sclerosis,
indicating a complex disorganization of the extracellular matrix, ﬁber
networks, as well as the cellular composition.
To overcome motion artifacts, Marrakchi-Kacem et al. (2016)
recently introduced an acquisition protocol for imaging the hippocam-
pal structure at 7 T. The full slab containing the hippocampus was
divided into separate slabs, each of them requiring a lower acquisition
time. The acquired single slabs were combined within a high-resolu-
tion, 3D-consistent slab, using a robust registration approach. They
found this method to be eﬀective in decreasing acquisition time and
hence motion artifacts when performing ultra-high resolution imaging
of the hippocampus.
Wisse et al. (2016) at 7 T MRI recently investigated the feasibility of
automatically segmenting hippocampal subunits and the entorhinal
cortex instead of performing a labour intensive manual segmentation,
and described a high accuracy for most subunits.
The development of an online computational anatomical atlas of the
hippocampus has been reported by Yushkevich et al. (2009). The atlas
was derived from postmortem specimens scanned with high-resolution
9.4 T MRI, to support subﬁeld segmentation in hippocampus imaging
and image analysis. In their recent work (Yushkevich et al., 2015), the
variability in the existing manual segmentation protocols to identify
hippocampal and parahippocampal substructures in MRI, qualitatively
as well as quantitatively, is described, to guide the development of a
harmonized substructure segmentation protocol.
Malformations of Cortical Development (MCD)
Higher resolution and improved gray/white matter contrast in the
MP2RAGE sequence at 7 T (O'Brien et al., 2014) enables better gray/
white matter diﬀerentiation. This proved valuable in the exclusion or
diagnosis of MCD, a common cause of drug-resistant epilepsy
(Barkovich et al., 2012), in a recent study by our group (Springer
et al., 2016). The diﬀerence between 3 T and 7 T was not statistically
signiﬁcant, however.
Some imaging signs of focal cortical dysplasias (FCD) (Blumcke and
Muhlebner, 2011) are often diﬃcult to depict or to exclude. These
include an ill-deﬁned, thickened cortex, or blurring of the gray-white
matter junction. These ﬁndings have to be conﬁrmed with multiplanar
imaging or isovoxel reconstructions to exclude volume averaging, and
could beneﬁt from the higher spatial resolution provided by 7 T. On 7 T
T2* FLASH images, a disruption of low-signal subcortical U ﬁbers in
the area of dysplasia was perceived (Madan and Grant, 2009). The
lesion described was depicted at both ﬁeld strengths on the MP-RAGE
and axial T2 TSE images, but in the future it is hoped that the improved
signal, contrast, and resolution of 7 T will help to depict more subtle
cortical dysplasias. Zucca et al. (2016) studied the correlations between
ex vivo 7 T imaging and histological and ultrastructural patterns of
type II FCD in 13 patients. On T2 weighted imaging a quantitative
region of interest (ROI) based analysis was performed to evidence the
presence and the border of type II cortical dysplasia. The quantitative
approach may help to diﬀerentiate the lesions and perilesional areas,
also in MRI-negative cases.
In a study by De Ciantis et al. (2016), 7 T MRI detected structural
abnormalities not previously depicted at lower ﬁeld strengths in six
(29%) out of 21 patients with focal epilepsy. The authors used a
dedicated protocol that included 3D T1w fast-spoiled gradient echo
(FSPGR), 3D susceptibility-weighted angiography (SWAN), 3D mag-
netization-prepared (MP)- FLAIR, 2D T2*-weighted targeted dual-echo
Gradient-Recalled Echo (GRE), 2D T2W TSE, 2D gray-white matter
tissue border enhancement (TBE) TSE- Inversion Recovery (IR)
(Costagli et al., 2014). The added value of 7 T in detecting structural
lesions was achieved using GRE, FLAIR, or both.
De Ciantis et al. also studied the potential of 7 T in vivo in imaging
polymicrogyria. In 10 adult patients suﬀering from polymicrogyria,
diagnosed before using 3 T MR imaging, they examined whether
additional characteristics might be revealed. Additional sequences at
ultra-high ﬁeld comprised 3D T2* susceptibility-weighted angiography
as well as 2D TBE TSE-IR. At 7 T, perisylvian polymicrogyria was
diagnosed to be bilateral in six patients, unilateral in three, and diﬀuse
in one. Of the six bilateral abnormalities four had been assessed as
unilateral at 3 T.
Cerebral Cavernous Malformations (CCMs)
Another possible cause for seizures are Cerebral Cavernous
Malformations (CCMs), for which MRI has been established as the
gold standard for diagnosis. In a recent study by Frischer et al., CCMs
and possibly associated Developmental Venous Anomalies (DVA), were
assessed in 24 patients on the SWI sequence at 7 in comparison to 3 T
(Frischer et al., 2012). Histopathology was available in 11 of 24
patients in surgically resected lesions to prove the diagnosis of CCMs
and potentially associated DVAs. Signiﬁcantly more CCMs were
identiﬁed on 7 T SWI than on 3 T SWI and a higher number of
associated DVAs were identiﬁed at 7 T compared to 3 T. Their
detection is relevant, since CCMs with associated DVAs have a higher
risk for clinically signiﬁcant hemorrhages.
Schlamann et al. (2010) examined ten patients with known
cavernomas using T2*-weighted GRE sequences at 1.5 T and at 7 T.
In one patient, an additional hypointensity was depicted at 7 T, which
was not visible at 1.5 T, even retrospectively. A better visualisation of
small cavernomas may help to explain cryptogenic seizures.
Fig. 3. Coronal T2-weighted images at 3 T (A) and 7 T (B) of a patient suﬀering from right-sided MTS type 1. Neuronal loss in all hippocampal subﬁelds CA1, CA2, CA3, and CA4.
Corresponding histopathological correlate, NeuN staining (C).
S. Trattnig et al. NeuroImage xx (xxxx) xxxx–xxxx
6
Brain tumors
For imaging brain tumors, attempts have been made to rely on non-
contrast-enhanced techniques. SWI at 7 T is used in brain tumors to
explore the intratumoral structure in gliomas, in particular with regard
to neoangiogenesis and microhemorrhage. The formation of patholo-
gical microvessels is a marker for a malignant transformation when
low-grade gliomas (World Health Organization (WHO) grades I and II)
show a progression to high-grade gliomas (WHO grades III and IV). In
addition, the oxygen extraction within a brain tumor may increase due
to elevated metabolism within the lesion, with higher deoxyhemoglobin
levels leading to more pronounced veins on SWI. Grabner et al.
observed that 7 T SWI appears to be capable of tracking changes in
brain tumor vasculature resulting from treatment with antiangiogenic
drugs (Grabner et al., 2011). Di Ieva et al. (2013) in 36 patients with
brain gliomas (grades II–IV) scanned at 7 T applied computer-aided
fractal image analysis. Higher fractal dimension values, as a measure of
geometric complexity of intratumoral SWI patterns, were found in
groups with a higher histologic grade. A statitistically signiﬁcant
diﬀerence was observed between histopathological groups, suggesting
that this approach may provide a morphometric imaging biomarker of
tumor grade. A more exact tumor grading with regard to localization of
areas of dediﬀerentiated cells could help in guiding biopsy.
A high resolution 7 T MRI protocol with a 0.8 mm isotropic
voxelsize has been proposed by de Rotte et al. (2014) for imaging the
pituitary gland. The feasibility of this was demonstrated in healthy
control subjects and patients with Cushing's disease. A second study of
patients with Cushing's disease by de Rotte et al. (2016) reported good
interobserver agreement of image assessment for diagnosis and exclu-
sion of pituitary microadenomas both for 7 T and 1.5 T MRI, while
lesions were detected more accurately with 7 T MRI.
Clinical fMRI
The primary clinical use of functional Magnetic Resonance Imaging
(fMRI) is in presurgical planning for patients with brain tumors and
epilepsy. Eloquent brain regions close to pathologies are mapped with
fMRI using a relevant task (Duﬀau, 2006), and regions deﬁned as
active are spared in surgery to ensure that vital function is preserved.
In practice, integrating fMRI results into the treatment plan leads to
more aggressive resection and decreased surgical time (Petrella et al.,
2006). The opportunity to increase the reliability of localizations or
reduce the scan time using 7 T is attractive, particularly as many
patients ﬁnd it hard to perform tasks and remain still for prolonged
periods. The relatively limited number of 7 T installations at hospital
sites and the fact that the current generation of 7 T MRI systems are
not certiﬁed for clinical use has meant that, to date, only a small
number of studies have been conducted on the feasibility and potential
advantages of performing clinical fMRI at 7 T.
In a study of 17 patients referred for presurgical localization of the
primary motor hand area, in which localizations were performed at
both 3 T and 7 T, Beisteiner et al. (2011) showed a clinically relevant
increase in functional sensitivity at the higher ﬁeld strength. A similar
study of language function yielded a more nuanced result, with
sensitivity being higher at 7 T in Wernicke's but not Broca's area, as
a result of increased susceptibility-related signal loss and Nyquist ghost
artefacts in the UHF measurements in the Broca region (Geissler et al.,
2014).
SNR increases with ﬁeld strength, but the sensitivity to blood
oxygenation level dependent (BOLD) signal changes in fMRI is
proportional not to image SNR but to time-series SNR (tSNR). The
thermal noise contribution to tSNR is quite constant with ﬁeld strength
whereas the noise arising from motion and physiological processes
both scale with image intensity, and thereby, ﬁeld strength (Kruger and
Glover, 2001). Thermal noise dominates at high resolution, so BOLD
sensitivity gains with ﬁeld are most signiﬁcant in that regime
(Triantafyllou et al., 2005). In presurgical planning, SNR gains
achieved with improved RF coils and higher ﬁeld have largely been
invested in improving the quality of results (Beisteiner, 2013) rather
than reducing scanning time or resolution. Imaging resolution has, in
fact, remaining broadly unchanged since early clinical fMRI work (see,
e.g. circa 2×2×3 mm3 voxels in (Beisteiner et al., 2000)). This wide-
spread use of “standard” resolution in presurgical planning explains the
relatively modest improvement in sensitivity with ﬁeld observed in the
two comprehensive 3 T - 7 T comparison studies carried out to date
(Beisteiner et al., 2011; Geissler et al., 2014).
A shift of resection margins by only 1 mm close to eloquent brain
areas may determine whether post-operative deﬁcits are reversible or
permanent (Haglund et al., 1994). Susceptibility-related distortions
scale with ﬁeld strength, so it is particularly important at UHF that
these be corrected. This can be done using a ﬁeld map acquired either
prior to, or after, the fMRI runs (Jezzard and Balaban, 1995; Robinson
and Jovicich, 2011). This ‘static’ approach captures B0 at a single point
in time, but is subject to error where there are signiﬁcant changes in B0
due to breathing or motion. In ‘dynamic’ ﬁeld mapping, in contrast, a
map of B0 is calculated from the phase of the Echo Planar Imaging
(EPI) volumes in the fMRI time series themselves. This requires the use
of multi-echo EPI (Hutton et al., 2002; Visser et al., 2012; Weiskopf
et al., 2005), ‘jittering’ of the echo time between diﬀerent values for odd
and even time points (Dymerska et al., 2015) or the use of a short pre-
scan which can be used to determine the phase oﬀset of each RF coil in
the array so that the phase from each image in an unmodiﬁed single-
echo EPI sequence can be converted to a ﬁeld map (Dymerska et al.,
2016). Correcting distortions has been shown to be clinically relevant
to decision-making in presurgical planning at 7 T (Dymerska et al.,
2014).
Head motion is a particular problem in clinical fMRI. Patients tend
to move more than healthy subjects and many of the tasks used in
presurgical planning – elbow ﬂexion, plantar ﬂexion, overt speech -
evoke head motion. Eﬀective and comfortable head ﬁxation is required
(Edward et al., 2000), as are imaging methods which are less sensitive
to motion. In accelerated EPI, for instance, modiﬁed schemes for the
acquisition of the GRAPPA reference lines (Griswold et al., 2002) have
recently been proposed which are more robust to motion and respira-
tion: If the reference lines are acquired in segmented fashion, all the
segments can be acquired for each slice in rapid succession, with low
ﬂip angle (Polimeni et al., 2015), replacing the conventional ‘consecu-
tive slices’ scheme by ‘consecutive segments’ which reduce motion and
phase changes between segments. Alternatively, reference lines can be
acquired with FLASH (Talagala et al., 2016). Both approaches lead to
an increase in tSNR in tasks involving motion at 7 T (Cardoso et al.,
2016a). In-plane acceleration allows a reduction of TE that is generally
necessary at UHF. The TR can be likewise reduced using simultaneous
multi-slice acquisition (Setsompop et al., 2012) which allows a reduc-
tion in TR by the multiband factor, increasing the SNR per unit time
with only a modest g-factor penalty (Barth et al., 2016).
Delayed reactions to task cues and modiﬁed hemodynamics close to
brain tumors (Fujiwara et al., 2004; Zaca et al., 2014) lead to consistent
deviations from expected response timing in the clinical context. These
have motivated the use of exploratory data analysis methods such as
Independent Component Analysis (ICA) (Beckmann, 2012), risk map-
ping (Beisteiner et al., 2000) and the use of signal changes in one run as
a predictor for the response in other runs (‘UNBIASED’) (Cardoso
et al., 2016b). ICA has been shown to be eﬀective in separating
activation from motion artefacts in 7 T clinical fMRI (Robinson et al.,
2013), while UNBIASED was able to detect signal changes which were
consistent and time-locked to the task, but which were delayed or
transient (Cardoso et al., 2016b). Resting-state acquisitions are in-
creasingly being explored as means to map functional networks in
patients who may have diﬃculty performing tasks (Kamran et al.,
2014), although to our knowledge, this has not yet been applied at
UHF.
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Ultra-high ﬁeld fMRI with high spatial and temporal resolution
opens up the possibility to study more subtle disruption and reorga-
nization of function, and allows weak activation to be detected in
previously undiagnosable patients with large and rapidly evolving
tumors and complex pathologies. In the example in Fig. 4, the
reliability of the response in a hand task, calculated with UNBIASED
(Cardoso et al., 2016b), is shown for a patient with 2 oligo-dendroglio-
mas grade II (1 right frontal, 1 right central). These were calculated
using 10 short fMRI runs with identical timing which were dynamically
corrected for distortion (Dymerska et al., 2016) and are overlaid on a
temporal mean distortion-corrected EPI image.
Simultaneous multi-slice acquisitions with more motion-robust in-
plane acceleration are expected to be a key element in achieving the
SNR per unit time required to allow the clinical fMRI community to use
higher resolution acquisitions, where the tSNR beneﬁts of UHF are
most evident. This is expected to allow UHF clinical fMRI to increas-
ingly supplant invasive diagnostic procedures such as intraoperative
cortical stimulation.
Arterial spin labeling (ASL) at 7 T
The longer T1 of blood (Rooney et al., 2007) and increased SNR at
7 T provide ostensibly attractive conditions for ASL, but B0 and B1
inhomogeneities make it hard to achieve a well-deﬁned labelling slab
and high labelling eﬃciency within SAR limits. Compared with
birdcage transmit coils, dedicated neck labelling coils provide eﬃcient,
low-SAR excitation of blood in the carotids, but SAR calculations need
to consider contributions from both the birdcage and neck coils (Wang
et al., 2008), and such systems are not yet broadly available. Low-SAR
labelling schemes such as ﬂow-sensitive alternating inversion recovery
(FAIR) (Kim, 1995) and Turbo-FLASH (Zuo et al., 2013) have been
used successfully at 7 T for both pseudocontinuous ASL (pCASL) and
pulsed ASL (PASL), while Gharig et al. (2012) found high-permittivity
dielectric pads eﬀective in compensating for lower B1 eﬃciency. FAIR
labelling has been combined with fast simultaneous multi-slice readout
to increased brain coverage for a particular imaging period, with low
SNR penalty (Ivanov et al., 2016). These methodological inroads are
expected to make ﬁrst clinical ASL studies viable in the near future.
MR spectroscopy
While MR spectroscopy (MRS) of animals, such as rats, at 7 T can
be dated back to the 1990 s, the feasibility of in vivoMRS in the human
brain at 7 T was ﬁrst shown in 2001 (Tkáč et al., 2001). Since this date,
despite considerable research, only few clinical applications were
published until 2010. These numbers increased only recently, which
is mainly related to the technical challenges associated with MRS, and
particularly, with MRS imaging (MRSI) at ≥7 T (Moser et al., 2012;
Posse et al., 2013). While common MRI methods beneﬁt from
increased SNR only, MRS also gains spectral resolution. This signiﬁ-
cantly improves both the number and the accuracy of detectable brain
metabolites (Bogner et al., 2012; Tkáč et al., 2001), thereby making
possible entirely new clinical applications.
Single-voxel MRS at 7 T
Most early 7 T MRS patient studies were restricted to single-voxel
MRS. For example, MRS in the caudate nucleus of Huntington's
disease (HD) patients showed lower NAA and lower creatine concen-
trations than in controls (van den Bogaard et al., 2011). In the
putamen, manifest HD patients show the aforementioned changes, as
well as lower glutamate. In the premanifest gene carriers, absolute
values of NAA, creatine, and glutamate were lower, although no
signiﬁcant diﬀerences were seen compared to healthy controls. In
early-manifesting HD the lower concentrations of NAA and creatine in
the caudate nucleus and putamen may indicate loss of neuronal
integrity and impaired energy metabolism. Changes in glutamate may
underpin the hypothesis of excitotoxicity of neurons (van den Bogaard
et al., 2011).
MRS also provides excellent biomarkers for disease progression, as
found in a longitudinal study (van den Bogaard et al., 2014). While van
den Bogaard et al. (2014) reported a signiﬁcant longitudinal decrease
of tNAA in the putamen of all subjects (three manifest and 10
premanifest HD gene carriers), in premanifest HD converters they
observed an elevated rate of tNAA decline in comparison to non-
converting premanifest HD, which however was not a statistically
signiﬁcant eﬀect.
Lower cerebellar NAA/Cr ratios were detected in patients with
hemiplegic migraine compared to control subjects (Zielman et al.,
2014). The reduced tNAA/tCre ratio in the cerebellum could be used a
potential early biomarker for neuronal loss or/and dysfunction
(Zielman et al., 2014).
Neurotransmitters - GABA, glutamate, glutamine
A particular improvement at 7 T was found in the detection of the
inhibitory neurotransmitter GABA, which is of low abundance and
therefore diﬃcult to quantify at lower B0. Investigation of GABA, Glu,
and Glutamine (Gln) in diﬀerent subregions of the anterior cingulate
cortex (ACC) showed diﬀerent relative concentration patterns (Dou
Fig. 4. Presurgical mapping of the primary hand motor representation in a patient with 2 oligo-dendrogliomas grade II (1 right frontal, 1 right central). Activation in primary motor,
somatosensory and supplementary areas can be seen in fMRI results showing voxels which were activated with between 20% and 100% reliability (overlaid on the mean EPI). No
smoothing or coregistration of the functional results was performed.
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et al., 2013). Dou et al. were able to show that in the pregenual (pg)
ACC elevated excitatory Glu and inhibitory GABA meet a local
segregation, in accordance with recently demonstrated receptor-archi-
tectonic distribution of GABAB receptors in ACC (Palomero-Gallagher
et al., 2009), whereas Gln distribution followed an AMPA receptor
pattern (Dou et al., 2013).
An increase of GABA was found in the pons and putamen in
Parkinson's disease (Emir et al., 2012). GABA measurements in the
hypothalamus and occipital cortex showed a trend toward a decrease in
GABA in the hypothalamus during hypoglycemia (Moheet et al., 2014).
GABA and glutamate were also altered in schizophrenia patients
compared to controls (Brandt et al., 2016; Marsman et al., 2014),
and a GABAergic dysfunction was found within the corticostriatal
pathways in children with primary complex motor stereotypes (Harris
et al., 2016).
Gabapentin, used for the treatment of neuropathic pain and
seizures, has been demonstrated to increase GABA concentration in
the visual cortex of rodents and humans (Cai et al., 2012).
Administration of gabapentin was associated with an average rise of
GABA concentrations of 55.7% (6.9–91.0%), though GABA concentra-
tion changes were small within-day (average 5.6%) and also between-
day (average 4.8%). A change in GABA levels, secondary to adminis-
tration of the drug, was correlated inversely to the GABA level of the
individual at baseline (R2=0.72). Further, the thalamic GABA/NAA
ratio was found to increase for well-controlled epilepsy and decrease
for poorly controlled epilepsy (Pan et al., 2013b).
Onco-markers
Single-voxel 7 T MRS also oﬀered enhanced sensitivity and speci-
ﬁcity for quantiﬁcation of the onco-marker 2-hydroxyglutarate (2-HG)
and associated metabolites, with implications for better monitoring of
the response of tumor patients to therapy (Emir et al., 2016). Initial
clinical results have also been obtained at 9.4 T, highlighting the
additional beneﬁts at further increased B0. This includes the direct
detection of important onco-markers such as 2-HG, which allows
IDH1/2-mutations to be identiﬁed non-invasively and without com-
plicated editing methods that lower the detection sensitivity (Bisdas
et al., 2016). The ﬁrst glioma patient results using 31P-MRSI have also
been reported at 9.4 T (Mirkes et al., 2016).
MR Spectroscopic imaging at 7 T - current and future directions
The number of MRSI studies in patients are also increasing at 7 T
and higher ﬁeld strengths, a fact which can partly be attributed to the
continuous improvement of MRSI acquisition and hardware technol-
ogy (Fillmer et al., 2015; Hangel et al., 2015; Pan et al., 2012; Strasser
et al., 2013). However, most of these studies are still limited to low
matrix sizes (i.e., ≤24×24) due to long measurement times
(Hetherington et al., 2014; Li et al., 2015; Pan et al., 2013a; Ratai
et al., 2008; Srinivasan et al., 2010).
Recent developments in MRSI
More recent acquisition approaches have overcome the limitations
of scan time and spatial resolution, allowing matrix sizes up to
128×128 (Hangel et al., 2016). The beneﬁts for the investigation of
brain tumors and MS have been shown recently with nominal in-plane
resolutions as low as 2–3 mm (i.e., a 64×64 to 100×100 matrix)
(Strasser et al., 2016a). Even at such high spatial resolution, single- and
multi-slice ultra-short TE MRSI sequences at 7 T can image up to nine
important brain metabolites (Povazan et al., 2015) in a clinically
feasible scan time of ~6–7 min (Hangel et al., 2015; Strasser et al.,
2016b). Apart from resolution improvements, also low-abundant J-
coupled brain metabolites can be mapped at UHF, which has not been
feasible previously (Heckova et al., 2016).
Clinical applications of MRSI
The assessment of lower glutathione (GSH) levels in lesions and the
GM of MS patients has become feasible for the ﬁrst time, using
spectral-edited MRSI at 7 T (Srinivasan et al., 2010). Recent data
suggest that metabolic alterations in NAA, GSH, and myo-Inositol
occur even beyond T2-visible MS lesions, and may thus predict the
location of lesion formation (Srinivasan et al., 2010; Strasser et al.,
2016a).
Using MRSI, a decrease of NAA/Cho and NAA/Cr in the hippo-
campi of mild traumatic brain injury patients could be detected
(Hetherington et al., 2014). Abnormalities in NAA/Cr ratios have been
successfully correlated to the outcome of surgical resection in epilepsy
(Pan et al., 2013a).
MRSI in adult X-linked adrenoleukodystrophy has shown changes
in metabolic ratios, such as lower NAA/Cr between diﬀerent pheno-
types and controls (Ratai et al., 2008).
Short-TE 3D-MRSI was able to provide a signiﬁcantly more
comprehensive neurochemical investigation of glioma and inﬁltrated
areas at 7 T (Li et al., 2015) compared to lower ﬁeld-strengths.
Mapping of the neurochemical ﬁngerprint of many brain patholo-
gies, such as tumors, delivers spatially resolved information about
metabolic activity, grade, or the distinction between recurrence and
pseudoprogression during treatment (Fig. 5) (Heckova et al., 2016).
Remaining challenges and future work
A number of challenges remain in clinical imaging at 7 T. The 3D -
FLAIR and 3D - T2 sequences at 7 T are still problematic, as they are
inherently more sensitive to B1 inhomogeneity and encounter SAR
limitations, and because of the prolonged T1 relaxation times at 7 T in
comparison to 3 T (Tallentyre et al., 2010), (Springer et al., 2016).
Variable ﬂip angle 3D sequences oﬀer an alternative to conventional
spin-echo T2-weighted sequences at 7 T, but in some cases need
further optimization to reproduce the desired contrasts. The temporal
lobes, for instance, have been found to be diﬃcult to assess with a
variable ﬂip-angle FLAIR sequence at 7 T because of poor B1 eﬃciency
(van Veluw et al., 2013; Visser et al., 2010). The 3D DIR sequence
beneﬁts from the use of higher resolution at 7 T, demonstrating
(beneath the hyperintense signal of outer, glia-rich layers of the cortex)
a slight decrease in the hyperintense signal of the cortex and lesions, of
cortical lesions as well as WM lesions, compared to 3 T (Springer et al.,
2016).
Optimization work still has to be conducted for the T1_FLASH
sequence at 7 T to enhance gray/white matter contrast. The detection
of intra- and extracellular methemoglobin, which is based on the
assessment of a T1-weighted sequence, was nevertheless possible using
the T1 FLASH sequence at 7 T (Springer et al., 2016).
The coil-related signal decrease in the posterior fossa poses a well
known problem, which can be mitigated by the use of dielectric pads
(O'Brien et al., 2013) and is likely to be overcome in a near future using
parallel transmit technology.
In SWI, although there are existing methods for combining separate
channel phase information, even in the absence of a reference volume
coil (Parker et al., 2014; Robinson et al., 2011; Robinson et al., 2015)
these have not been implemented by all vendors for online reconstruc-
tion. The implementation of automatic reconstruction on the scanner
console could increase the applicability of SWI, or other methods using
phase information, such as Quantitative Susceptibility Mapping
(Deistung et al., 2016; Shmueli et al., 2009), in a clinical setting.
In summary, increased SNR through higher static magnetic ﬁeld
strength can be translated into higher spatial resolution or contrast, or
can theoretically be invested into a reduction in scan time (particularly
in spectroscopy). In some applications, increasing the resolution at 7 T
(e.g. from 1.0 mm to 0.7 mm isotropical) may nonetheless lead to a
slight increase in scan times, which may be considered worthwhile if it
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leads to an increase in diagnostic conﬁdence. fMRI beneﬁts from
higher static magnetic ﬁeld, which leads to more reliable presurgical
brain tumor evaluation. The high potential of MRSI at UHF has already
been shown in several clinical applications.
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